We are the global leaders in regenerative solutions. Our bioresorbable implant is the first of its kind to be successfully developed and commercialized for surgical use.
Our implants heal bone naturally. They are made of a bioresorbable polymer that dissolves over time, leaving only natural, healthy bone. This reduces post-surgery complication rates significantly, compared to permanent implants.
Our products are trusted and used by surgeons across Asia, Europe, Australia, and the Americas.
We are approved for use across several regions and operate in over 20 countries and autonomous regions.
Our Osteoplug in plug and strip configuration fill craniotomy gaps effortlessly. They also promote bone tissue integration, from the skull to the bone flap.
With a one-step process, Osteopore's mesh products may support the reconstruction of the skull base entry. The regenerative scaffold fully resorbs by hydrolysis in 18-24 months leaving only natural bone.
We harness the body’s regenerative capacity to rebuild lost tissues. Osteopore (OSX) creates bioresorbable implants by leveraging the combined technologies of tissue engineering, regenerative medicine, and 3d printing techniques.
With in-situ tissue engineering, surgeons and dentists reduce time to treatment—there is no need for them to extensively manipulate or culture cells and material outside of the body.
EN ISO 13485
US FDA QSR-21 CFR Part 820
We strive to be a World Leader in Bioresorbable Scaffold Tissue Engineering by using Cutting-Edge Technology. We want to bring "A Message of Hope in Restoring Tissue to Normality" through the development of new scaffolds technologies and manufacturing medical devices which will repair and regenerate tissue that is both safe and effective while complying with all regulatory requirements for use.
View details